ArticleVaccines2022

Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab.

Victoria Furer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.